HEALTHSTAT NEWS
FDA finally analyzed its own youth tobacco data
The FDA analyzed its own data on youth tobacco use. The article highlights strong reporting by Lizzy on a patient who received retatrutide, though the focus remains on the FDA's delayed action regarding youth tobacco data.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
- Eli Lilly stock surged after its next-generation weight loss drug posted record results
- Big tobacco uses cigarette playbook to help sell ultra-processed foods, journal reveals
- STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program